Skip to main content
AdChoices
Canada
World
Business
Investing
Watchlist
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Podcasts
Bausch & Lomb
Follow
You must be logged in to follow.
Log In
Create free account
Latest
opinion
Eight dance events from around the country that are worth the trip
Rebecca Ritzel
October 6, 2022
inside the market
The former Valeant exits Canada’s big-stock index; energy stock added
September 6, 2022
report on business
Bausch Health shares plummet on adverse drug patent ruling
July 28, 2022
market news
The close: Stocks rise, bond yields sink, after weak GDP reading; Bausch Health dives 50% on patent ruling
July 28, 2022
report on business
Joseph Papa stepping down from Bausch + Lomb, will remain CEO until successor named
July 20, 2022
u.s. business
Bausch Health suspends plans for Solta IPO
June 17, 2022
report on business
Bausch Health reports US$69-million first-quarter loss, revenue down from year ago
May 10, 2022
report on business
Laval-based pharmaceutical company Bausch + Lomb plans US$788-million IPO
May 2, 2022
international business
Bausch + Lomb files to go public in the U.S. and Canada, discloses revenue jump
January 14, 2022
inside the market
Bausch Health dip buyers are winning ahead of Q3 earnings
Ted Dixon
October 29, 2021
inside the market
Market movers: Stocks that saw action on Tuesday - and why
August 3, 2021
report on business
Bausch announces IPO for medical aesthetics business as second-quarter revenues surge
August 3, 2021
report on business
Bausch Health preparing for spinoff of eye-care unit this fall
May 4, 2021
report on business
Bausch Health selling stake in Egypt’s Amoun for $740-million
March 31, 2021
report on business
Bausch Health names Sam Eldessouky as next CFO
March 11, 2021
inside the market
The ‘absurdly wide’ valuation spread between value and growth stocks holds lots of opportunity
December 8, 2020
report on business
Easy money: A new wave of cheap debt is dramatically improving Canadian companies’ prospects
November 23, 2020
report on business
Bausch Health says COVID-19 cut third-quarter revenue by $150-million
November 3, 2020